← Back to Search

E-liquid Standards for Vaping Appeal

N/A
Recruiting
Led By Theodore L Wagener, PhD
Research Sponsored by Ohio State University Comprehensive Cancer Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 hour
Awards & highlights

Study Summary

This trial seeks to understand how nicotine levels and types in e-cigarettes affect appeal to both young adult vapers and adult smokers.

Who is the study for?
This trial is for young adult e-cigarette users and older smokers who can go without any nicotine products for 12 hours before the study visit. Participants must be able to read and speak English.Check my eligibility
What is being tested?
The Sweet Spot Study tests how appealing electronic cigarettes are when they have different levels of freebase nicotine. It involves trying various e-liquids labeled EC A through EC J in a controlled setting.See study design
What are the potential side effects?
Potential side effects may include typical reactions to vaping, such as throat irritation, coughing, dizziness, or nausea. The specific side effects will depend on individual sensitivity to nicotine and the varying formulations of the e-liquids.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 hour
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 hour for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Behavioral Intentions for continued use
Degree of liking or disliking of sensations
Intensity of sensory attributes
Secondary outcome measures
Subjective Appeal

Trial Design

2Treatment groups
Active Control
Group I: Young adult EC usersActive Control10 Interventions
Young Adult EC users
Group II: Older adult smokersActive Control10 Interventions
Adult smokers

Find a Location

Who is running the clinical trial?

Ohio State University Comprehensive Cancer CenterLead Sponsor
320 Previous Clinical Trials
289,963 Total Patients Enrolled
Theodore L Wagener, PhDPrincipal InvestigatorOhio State University Comprehensive Cancer Center
4 Previous Clinical Trials
1,945 Total Patients Enrolled

Media Library

Young adult EC users Clinical Trial Eligibility Overview. Trial Name: NCT05864586 — N/A
Nicotine Research Study Groups: Young adult EC users, Older adult smokers
Nicotine Clinical Trial 2023: Young adult EC users Highlights & Side Effects. Trial Name: NCT05864586 — N/A
Young adult EC users 2023 Treatment Timeline for Medical Study. Trial Name: NCT05864586 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What criteria must an individual meet to be eligible for enrollment into this research?

"To participate in this trial, applicants must be nicotine-dependent and within the age bracket of 21 to 50. Currently, 132 participants are needed for the clinical investigation."

Answered by AI

Is the age limit for eligibility to this clinical trial below 70 years?

"The investigators of this medical trial are searching for individuals aged 21 to 50 years old."

Answered by AI

Is there an ongoing enrollment period for this trial?

"According to clinicaltrials.gov, enrollment for this particular study has concluded; the trial was initially posted on June 1st 2023 and last updated May 9th 2023. However, there are still 14 other trials available that are actively recruiting participants at present."

Answered by AI

Who else is applying?

What site did they apply to?
Ohio State University Comprehensive Cancer Center
What portion of applicants met pre-screening criteria?
Met criteria

Why did patients apply to this trial?

It just seemed like something I'd be interested in since I already currently smoke cigarettes and disposable vapes!
PatientReceived 2+ prior treatments
Recent research and studies
clinicaltrials.govStudy
Developing E-liquid Product Standards (Sweet Spot Study)
Theodore Wagener 2023. "Developing E-liquid Product Standards (Sweet Spot Study)". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05864586.
~56 spots leftby Dec 2024
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top